Portfolio Update

RNS Number : 4162N

Intl. Biotechnology Trust PLC

25 October 2016

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

Portfolio Update as at 30 September 2016

Net Assets	£229m
Net Assets per share	611p
Share price	548p
Total value of unquoted investments	£23m
Total number of portfolio companies	85

Top Ten Holdings

Company Name	% NAV
Biogen	7.5
Celgene	6.6
Regeneron	6.1
Genmab	4.4
Incyte	4.3
Gilead	3.9
Illumina	3.6
Amgen	3.6
Alexion	3.6
Biomarin	3.1
	-----------
Total	46.7

Geographical Allocation	% NAV
US & Canada	78
Europe & UK	22
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	90
Unquoted	10
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	52
Mid Cap =USD1-10BN	25
Small Cap <USD1BN	23
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	35
Orphan	17
CNS	11
Inflammation	10
Ophthalmology	8
Medtech	2
Other	17
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

25 OCTOBER 2016

 

END

 

 

PFUBBBDGUUDBGLU